Haipeng Cheng is a renowned Senior Investment Director with specialized expertise in Investments and Life Sciences. With a Master's Degree in Genetics from Zhejiang University and a PhD in Genetics from Fudan University, he has made remarkable contributions to the field of life sciences.

Haipeng Cheng's professional journey began as a Research Scientist at United Gene Holdings, followed by his tenure as a Research Associate at Northwestern University, Feinberg School of Medicine, and The University of Chicago. He later served as a Postdoctoral Scholar, Senior Investment Analyst, and Investment Director at Sangel Capital Corp. achieving significant milestones in his professional career.

As Senior Investment Director at Sangel Capital Corp., Haipeng Cheng has applied his vast knowledge and experience in life sciences to identify and capitalize on investment opportunities in health-oriented fields. His approach focuses on understanding the science and technology involved in each investment prospect.